Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease

被引:32
|
作者
Dowla, Shima [1 ,2 ]
Aslibekyan, Stella [3 ]
Goss, Amy [4 ]
Fontaine, Kevin [1 ]
Ashraf, Ambika P. [5 ]
机构
[1] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL USA
[2] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA
[4] Univ Alabama Birmingham, Dept Nutr, Birmingham, AL USA
[5] Univ Alabama Birmingham, Dept Pediat, Div Pediat Endocrinol, Birmingham, AL 35294 USA
关键词
Nonalcoholic fatty liver disease; Metabolic syndrome; Dyslipidemia; Childhood obesity; Pediatric; METABOLIC SYNDROME; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; OBESE CHILDREN; STEATOHEPATITIS; ATHEROSCLEROSIS; DIAGNOSIS; ETHNICITY; HISTOLOGY; LIPIDS;
D O I
10.1016/j.jacl.2018.03.089
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: With the increasing prevalence of childhood obesity, nonalcoholic fatty liver disease (NAFLD) has emerged as the most common cause of pediatric chronic liver disorder. Factors underlying the pathophysiology of NAFLD remain poorly defined. OBJECTIVE: This study aimed to describe the metabolic characteristics of children with NAFLD differing in race/ethnicity and to test associations between dyslipidemia and NAFLD. METHODS: A retrospective chart review was conducted at a tertiary referral university hospital among 309 children with a diagnosis of NAFLD. RESULTS: Participants (mean age 12.5 +/- 3.4 years) were 64% male, 63% white, 23% Hispanic, and 14% black. Hispanic children were diagnosed with NAFLD at a significantly younger age (10.6 +/- 3.1 years, P<.0001) and lower body mass index (31.5 +/- 6.8 kg/m(2), P<.0001) than their white and black counterparts. For the entire cohort, prevalence of systolic hypertension was 41%, diabetes 14%, elevated cholesterol 42%, elevated non high-density lipoprotein cholesterol (non HDL-C) 58%, elevated low-density lipoprotein cholesterol 36%, elevated triglycerides (TG) 88%, and low high-density lipoprotein cholesterol 77%. Whites had elevated non HDL-C, low-density lipoprotein cholesterol, and TG compared to blacks or Hispanics. Serum TG and non HDL-C were significantly correlated to alanine aminotransferase (r=0.18, P=.01; r=0.16, P=.02), respectively, and persisted after adjusting for age and body mass index. CONCLUSION: Cardiometabolic derangements, especially dyslipidemia, are highly prevalent in children with NAFLD and differ based on race/ethnicity. Serum TG and non HDL-C may play an important role in the pathophysiology of pediatric NAFLD. (C) 2018 National Lipid Association. All rights reserved.
引用
收藏
页码:981 / 987
页数:7
相关论文
共 50 条
  • [31] Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease
    Stergios A. Polyzos
    Irene Lambrinoudaki
    Dimitrios G. Goulis
    [J]. Hormones, 2022, 21 : 375 - 381
  • [32] Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
    Alkhouri, Naim
    Carter-Kent, Christine
    Elias, Michael
    Feldstein, Ariel E.
    [J]. CLINICAL LIPIDOLOGY, 2011, 6 (03) : 305 - 314
  • [33] Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
    Akhtar, Daud H.
    Iqbal, Umair
    Vazquez-Montesino, Luis Miguel
    Dennis, Brittany B.
    Ahmed, Aijaz
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (04) : 362 - 370
  • [34] GALLSTONE DISEASE IS NOT ASSOCIATED WITH LIVER FIBROSIS AND NONALCOHOLIC STEATOHEPATITIS IN NONALCOHOLIC FATTY LIVER DISEASE
    Yilmaz, Y.
    Ayyildiz, T.
    Akin, H.
    Colak, Y.
    Ozturk, O.
    Senates, E.
    Tuncer, I.
    Dolar, E.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S553 - S554
  • [35] Smoking is not associated with nonalcoholic fatty liver disease
    Norberto C Chavez-Tapia
    Javier Lizardi-Cervera
    Oliver Perez-Bautista
    Martha H Ramos-Ostos
    Misael Uribe
    [J]. World Journal of Gastroenterology, 2006, (32) : 5196 - 5200
  • [36] Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach
    Anna Alisi
    Ariel E. Feldstein
    Alberto Villani
    Massimiliano Raponi
    Valerio Nobili
    [J]. Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 152 - 161
  • [37] Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
    Dulshan Jayasekera
    Phillipp Hartmann
    [J]. World Journal of Hepatology, 2023, (05) : 609 - 640
  • [38] Hedgehog Pathway and Pediatric Nonalcoholic Fatty Liver Disease
    Swiderska-Syn, Marzena
    Suzuki, Ayako
    Guy, Cynthia D.
    Schwimmer, Jeffrey B.
    Abdelmalek, Manal F.
    Lavine, Joel E.
    Diehl, Anna Mae
    [J]. HEPATOLOGY, 2013, 57 (05) : 1814 - 1825
  • [39] Clinical advances in pediatric nonalcoholic fatty liver disease
    Schwimmer, Jeffrey B.
    [J]. HEPATOLOGY, 2016, 63 (05) : 1718 - 1725
  • [40] Nonalcoholic Fatty Liver Disease in Pediatric Obese Patients
    Brad, Giorgiana Flavia
    Tamasanu, Raluca Corina
    Latcu, Manuela Ioana
    Bugi, Meda Ada
    Marginean, Otilia
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 413 - 413